S
VRTX icon

Seeyond’s Vertex Pharmaceuticals VRTX Stock Holding History

Seeyond’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.46M Sell
8,511
-2,396
-22% -$730K 0.24% 139
2022
Q3 		$3.16M Buy
10,907
+1,167
+12% +$336K 0.38% 60
2022
Q2 		$2.74M Sell
9,740
-3,003
-24% -$804K 0.31% 76
2022
Q1 		$3.33M Sell
12,743
-380
-3% -$90.2K 0.33% 61
2021
Q4 		$2.88M Buy
13,123
+3,655
+39% +$711K 0.27% 90
2021
Q3 		$1.72M Sell
9,468
-2,434
-20% -$475K 0.17% 203
2021
Q2 		$2.4M Sell
11,902
-86
-0.7% -$18K 0.22% 129
2021
Q1 		$2.58M Buy
11,988
+78
+0.7% +$17.1K 0.26% 96
2020
Q4 		$2.81M Buy
11,910
+1,129
+10% +$259K 0.29% 70
2020
Q3 		$2.93M Buy
10,781
+1,462
+16% +$403K 0.32% 60
2020
Q2 		$2.71M Sell
9,319
-1,075
-10% -$291K 0.31% 60
2020
Q1 		$2.47M Buy
10,394
+982
+10% +$225K 0.34% 61
2019
Q4 		$2.06M Sell
9,412
-334
-3% -$67.6K 0.22% 152
2019
Q3 		$1.65M Buy
9,746
+4,607
+90% +$815K 0.17% 200
2019
Q2 		$942K Buy
5,139
+622
+14% +$109K 0.1% 331
2019
Q1 		$831K Hold
4,517
– – 0.08% 370
2018
Q4 		$749K Buy
+4,517
New +$783K 0.1% 295

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Seeyond's VRTX Position: Q4 2022 in Review

Seeyond reduced its Vertex Pharmaceuticals (VRTX) stake by 22% in Q4 2022, selling an estimated $730K and leaving 8,511 shares worth $2.46M. The position accounts for 0.24% of the portfolio, ranked #139.

Seeyond first reported a position in VRTX in Q4 2018 and has held it in 17 quarters since. The position peaked at $3.33M in Q1 2022. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

  • Seeyond held 8,511 shares of Vertex Pharmaceuticals worth $2.46M as of Q4 2022.
  • Seeyond sold 2,396 Vertex Pharmaceuticals shares in Q4 2022, an estimated $730K.
  • Vertex Pharmaceuticals made up 0.24% of Seeyond's portfolio in Q4 2022, its #139 holding.
  • Seeyond first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's Vertex Pharmaceuticals position peaked at $3.33M in Q1 2022.
  • 1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.